Sigma Planning Corp Sells 9160 Shares of Gilead Sciences, Inc. (GILD)


Avalon Global Asset Management Llc sold 20,000 shares as Gilead Sciences Inc (GILD)'s stock declined 8.05%. The stock decreased 4.95% or $2.72 during the last trading session, reaching $52.18.

In the transaction dated January 11, 2018, the great number of shares disposed came courtesy the EVP Comm&Acs ALA, Corp&Med Aff; Alton Gregg H disposed a total of 30,000 shares at an average price of $79, amounting to approximately $2,370,000. Sensata Technologies Holding N.V. (NYSE:ST) has risen 16.67% since February 6, 2017 and is uptrending. It has underperformed by 38.50% the S&P500. Ltd. increased its stake in Gilead Sciences, Inc. MUFG Securities EMEA plc now owns 104,880 shares of the biopharmaceutical company's stock valued at $8,497,000 after acquiring an additional 99,000 shares during the last quarter. The hedge fund held 3,288 shares of the property-casualty insurers company at the end of 2017Q3, valued at $302,000, down from 7,386 at the end of the previous reported quarter. Dt Investment Partners Llc who had been investing in Exelon Corp for a number of months, seems to be bullish on the $35.04B market cap company.

Gilead Sciences (GILD) traded up $2.01 during mid-day trading on Tuesday, hitting $80.38.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. It has underperformed by 39.93% the S&P500.

Since December 14, 2017, it had 0 insider buys, and 2 insider sales for $1.39 million activity. The stock witnessed 6.05% gains, 6.18% gains and 7.12% gains for the 1-month, 3-month and 6-month period, respectively. Another trade for 48,059 shares valued at $4.54M was made by Winter Matthew E on Tuesday, August 15.

Among 23 analysts covering Merck & Co. Also, there are 1 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.77 average brokerage recommendation. Therefore 70% are positive. The Allstate Corporation had 47 analyst reports since August 4, 2015 according to SRatingsIntel. Compass Point maintained it with "Neutral" rating and $66 target in Wednesday, August 5 report. The stock of CoreSite Realty Corporation (NYSE:COR) has "Hold" rating given on Wednesday, January 17 by Credit Suisse. Finally, BidaskClub raised shares of Gilead Sciences from a "sell" rating to a "hold" rating in a research note on Tuesday, January 16th. As per Friday, July 21, the company rating was maintained by BMO Capital Markets. Morgan Stanley maintained Schlumberger Limited (NYSE:SLB) on Tuesday, April 19 with "Overweight" rating. The firm earned "Outperform" rating on Friday, February 5 by Leerink Swann. JPMorgan Chase & Co. set a $85.00 price target on Gilead Sciences and gave the company a "buy" rating in a report on Wednesday, October 25th. On Friday, September 25 the stock rating was upgraded by Guggenheim to "Buy".

Loeb Partners Corporation, which manages about $405.10M and $327.19M US Long portfolio, upped its stake in Retail Opportunity Invts Cor (NASDAQ:ROIC) by 20,500 shares to 106,700 shares, valued at $2.03 million in 2017Q3, according to the filing. Stephens Inc Ar stated it has 0.2% in Gilead Sciences, Inc.

Investors sentiment increased to 1.54 in Q3 2017. Its the same as in 2017Q2. First Interstate Bancshares reported 80,315 shares or 1.2% of all its holdings. Winslow Evans And Crocker reported 540 shares stake. Mycio Wealth Ptnrs has 10,426 shares for 0.1% of their portfolio. Illinois-based Front Barnett Assoc Limited Com has invested 1.58% in Schlumberger Limited (NYSE:SLB). Alabama-based Fjarde Ap has invested 0.05% in Sensata Technologies Holding N.V. (NYSE:ST). American Century Companies holds 3.39M shares or 0.28% of its portfolio. (NYSE:PBF). Citadel Advsrs Ltd has 0.01% invested in PBF Energy Inc. Comm Natl Bank accumulated 52,094 shares. Calamos Advsr Ltd Liability Corp reported 318,834 shares. Westwood Holdings Gru invested 0.03% in Schlumberger Limited (NYSE:SLB).

Since August 30, 2017, it had 0 insider buys, and 11 selling transactions for $44.82 million activity. Alton Gregg H sold $1.11 million worth of Gilead Sciences, Inc. 51,820 shares were sold by Washington Robin L, worth $4.40 million.

The firm has floated short ratio of 1.68%, hold to candle to sentiment indicator of Short Ratio, its stand at 2.66. Its up 0.10, from 0.93 in 2017Q2. It is positive, as 96 investors sold GILD shares while 488 reduced holdings.

The company reported its last earnings Actual EPS of $2.27/share.

Sigma Planning Corp reduced its stake in shares of Gilead Sciences, Inc. Eqis Capital Mgmt invested in 0.01% or 2,880 shares. Insider ownership decreased by a total of 503985 shares, which suggests that GILD's key executives are feeling less optimistic about the outlook for the stock. Mason Street Advisors Lc holds 0.04% of its portfolio in PBF Energy Inc. (NASDAQ:GILD). Muhlenkamp & Comm accumulated 224,147 shares. The insider now directly owns 45,488 shares worth $3,564,895. Hsbc Pcl accumulated 2.75M shares. Florida-based Raymond James Na has invested 0.15% in Gilead Sciences, Inc. (NASDAQ:GILD) or 18,455 shares. Laurion Mngmt Ltd Partnership stated it has 4,800 shares. Jefferies maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Monday, August 28 with "Hold" rating. State Board Of Administration Of Florida Retirement holds 0.41% of its portfolio in Gilead Sciences, Inc. Montag A & Associates Inc. acquired a new position in Gilead Sciences during the third quarter worth about $3,977,000.



Other news